Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Fortschritte Der Neurologie-Psychiatrie|March 10, 2010
[Adherence to therapy in multiple sclerosis and schizophrenia]P Bussfeld, J CzekallaThe Journal of Clinical Psychiatry|March 10, 2001
Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychoticsJ Czekalla, S Kollack-Walker, C M BeasleyPharmacopsychiatry|October 29, 1997
The effect of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramineJ Czekalla, M Gastpar, W D Hübner, et al.Journal of Child and Adolescent Psychopharmacology|August 10, 2000
Efficacy and safety findings from naturalistic fluoxetine drug treatment in adolescent and young adult patientsR W Dittmann, J Czekalla, H P Hundemer, et al.The Journal of Clinical Psychiatry|April 18, 2001
Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosisJ Czekalla, C M Beasley, M A Dellva, et al.Psychopharmacology|November 20, 2001
Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapineD Hubl, H Kleinlogel, L Frölich, et al.Biological Psychiatry|June 6, 2000
Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging studyH R Volz, S Riehemann, I Maurer, et al.Pharmacopsychiatry|February 12, 2005
A simple switching strategy for inadequately treated patients with schizophrenia to olanzapine: changes in psychopathology and subjective well-beingM Kluge, P M Wehmeier, R W Dittmann, et al.Pageof 1